Deerfield Mgmt, L.P. 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 10:10 am Unchanged | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Deerfield Mgmt, L.P. | 1,324,214 4.960% | 0 (Unchanged) | Filing |
| 2022-05-11 1:50 pm Purchase | 2022-05-10 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Deerfield Mgmt, L.P. | 1,324,214 5.040% | 1,324,214 (New Position) | Filing |